Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 10 | 2021 | 3499 | 1.310 |
Why?
|
Data Mining | 4 | 2020 | 552 | 1.120 |
Why?
|
Decision Support Systems, Clinical | 4 | 2022 | 1172 | 1.100 |
Why?
|
Systems Biology | 3 | 2017 | 481 | 0.990 |
Why?
|
Veterans | 4 | 2024 | 2656 | 0.960 |
Why?
|
Medical Informatics | 5 | 2024 | 733 | 0.950 |
Why?
|
Pattern Recognition, Automated | 3 | 2016 | 993 | 0.930 |
Why?
|
User-Computer Interface | 5 | 2016 | 1393 | 0.880 |
Why?
|
Candida albicans | 3 | 2021 | 372 | 0.860 |
Why?
|
Programming Languages | 2 | 2017 | 130 | 0.830 |
Why?
|
Models, Genetic | 3 | 2017 | 3430 | 0.780 |
Why?
|
Pyrazinamide | 1 | 2021 | 60 | 0.730 |
Why?
|
Genomics | 10 | 2023 | 5829 | 0.730 |
Why?
|
Berberine | 1 | 2020 | 26 | 0.720 |
Why?
|
Electronic Health Records | 11 | 2023 | 4822 | 0.710 |
Why?
|
Stomatitis | 2 | 2013 | 271 | 0.670 |
Why?
|
Data Display | 2 | 2021 | 174 | 0.630 |
Why?
|
Streptococcus | 1 | 2019 | 197 | 0.630 |
Why?
|
Databases, Genetic | 4 | 2017 | 1741 | 0.610 |
Why?
|
Models, Theoretical | 3 | 2017 | 3571 | 0.610 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2019 | 1131 | 0.590 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3777 | 0.570 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4739 | 0.550 |
Why?
|
Markov Chains | 2 | 2017 | 965 | 0.540 |
Why?
|
Semantics | 1 | 2019 | 612 | 0.510 |
Why?
|
Health Level Seven | 4 | 2023 | 35 | 0.500 |
Why?
|
Synthetic Biology | 2 | 2019 | 185 | 0.500 |
Why?
|
Software | 6 | 2022 | 4431 | 0.500 |
Why?
|
Cross Infection | 2 | 2015 | 1422 | 0.500 |
Why?
|
Sucking Behavior | 1 | 2015 | 28 | 0.490 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 585 | 0.470 |
Why?
|
Genes | 2 | 2010 | 1820 | 0.470 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 492 | 0.460 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2576 | 0.460 |
Why?
|
Genome, Bacterial | 1 | 2019 | 785 | 0.450 |
Why?
|
Audiovisual Aids | 1 | 2014 | 99 | 0.440 |
Why?
|
Microarray Analysis | 3 | 2019 | 748 | 0.440 |
Why?
|
Drug Resistance, Bacterial | 1 | 2021 | 1048 | 0.440 |
Why?
|
Algorithms | 7 | 2017 | 14025 | 0.440 |
Why?
|
Saliva | 2 | 2015 | 828 | 0.430 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 686 | 0.410 |
Why?
|
Computer Simulation | 3 | 2016 | 6224 | 0.410 |
Why?
|
Antitubercular Agents | 1 | 2021 | 1374 | 0.400 |
Why?
|
Professional Practice | 1 | 2013 | 313 | 0.380 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2013 | 197 | 0.370 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1912 | 0.340 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2452 | 0.340 |
Why?
|
Leukemia, Myeloid | 1 | 2013 | 693 | 0.330 |
Why?
|
Models, Statistical | 3 | 2021 | 5081 | 0.330 |
Why?
|
Dipeptides | 1 | 2011 | 386 | 0.330 |
Why?
|
Computer Graphics | 2 | 2008 | 338 | 0.320 |
Why?
|
Leukocyte Count | 1 | 2012 | 1597 | 0.310 |
Why?
|
Medical Oncology | 2 | 2017 | 2320 | 0.310 |
Why?
|
Thrombosis | 1 | 2022 | 2944 | 0.310 |
Why?
|
Tuberculosis | 1 | 2021 | 2017 | 0.300 |
Why?
|
Information Theory | 1 | 2008 | 49 | 0.290 |
Why?
|
Behavior | 1 | 2011 | 540 | 0.290 |
Why?
|
Bayes Theorem | 4 | 2014 | 2329 | 0.290 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 710 | 0.290 |
Why?
|
Antifungal Agents | 3 | 2021 | 752 | 0.290 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1212 | 0.280 |
Why?
|
United States Department of Veterans Affairs | 2 | 2022 | 930 | 0.280 |
Why?
|
Phenotype | 3 | 2013 | 16575 | 0.270 |
Why?
|
Transplantation Conditioning | 1 | 2013 | 1591 | 0.270 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2017 | 15920 | 0.260 |
Why?
|
Alcoholism | 1 | 2017 | 1973 | 0.260 |
Why?
|
Bacterial Proteins | 1 | 2019 | 3836 | 0.260 |
Why?
|
Clostridium Infections | 1 | 2012 | 557 | 0.250 |
Why?
|
Disease | 1 | 2011 | 670 | 0.250 |
Why?
|
Proteomics | 3 | 2008 | 3840 | 0.240 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3594 | 0.230 |
Why?
|
Humans | 51 | 2024 | 761222 | 0.230 |
Why?
|
Terminology as Topic | 2 | 2020 | 1528 | 0.230 |
Why?
|
Genetic Engineering | 1 | 2010 | 930 | 0.230 |
Why?
|
Radiation Injuries | 1 | 2011 | 1191 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3051 | 0.220 |
Why?
|
Engineering | 1 | 2004 | 56 | 0.220 |
Why?
|
Hearing Aids | 1 | 2004 | 58 | 0.220 |
Why?
|
Proteins | 2 | 2010 | 5993 | 0.210 |
Why?
|
Genome | 3 | 2018 | 1738 | 0.210 |
Why?
|
Indenes | 1 | 2023 | 59 | 0.210 |
Why?
|
Feeding Behavior | 1 | 2015 | 3183 | 0.210 |
Why?
|
Tryptophan | 1 | 2024 | 480 | 0.200 |
Why?
|
Drug Discovery | 3 | 2021 | 1048 | 0.200 |
Why?
|
Acoustics | 1 | 2004 | 243 | 0.200 |
Why?
|
Cluster Analysis | 2 | 2021 | 2706 | 0.200 |
Why?
|
Multiple Myeloma | 2 | 2017 | 5145 | 0.200 |
Why?
|
Triglycerides | 2 | 2019 | 2457 | 0.190 |
Why?
|
Halogenation | 1 | 2020 | 48 | 0.180 |
Why?
|
Knowledge Bases | 1 | 2021 | 97 | 0.180 |
Why?
|
Siderophores | 1 | 2020 | 61 | 0.180 |
Why?
|
Fluconazole | 1 | 2020 | 156 | 0.170 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.170 |
Why?
|
Streptomyces | 1 | 2019 | 91 | 0.170 |
Why?
|
Neoplasms | 3 | 2019 | 22142 | 0.160 |
Why?
|
Robotics | 1 | 2006 | 817 | 0.160 |
Why?
|
Quality of Life | 1 | 2021 | 13367 | 0.160 |
Why?
|
Principal Component Analysis | 1 | 2002 | 942 | 0.160 |
Why?
|
Gene Regulatory Networks | 2 | 2019 | 1743 | 0.160 |
Why?
|
Auditory Perception | 1 | 2004 | 584 | 0.160 |
Why?
|
International Classification of Diseases | 3 | 2013 | 915 | 0.160 |
Why?
|
Publications | 1 | 2021 | 194 | 0.160 |
Why?
|
Intracellular Space | 1 | 2019 | 197 | 0.160 |
Why?
|
Gene Transfer, Horizontal | 1 | 2019 | 144 | 0.160 |
Why?
|
Endodeoxyribonucleases | 1 | 2019 | 164 | 0.150 |
Why?
|
Itraconazole | 1 | 2018 | 43 | 0.150 |
Why?
|
Melatonin | 1 | 2023 | 668 | 0.150 |
Why?
|
Socioeconomic Factors | 2 | 2022 | 7804 | 0.150 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11855 | 0.150 |
Why?
|
Lovastatin | 1 | 2018 | 115 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2013 | 5666 | 0.150 |
Why?
|
Biomedical Research | 1 | 2013 | 3434 | 0.150 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2019 | 392 | 0.150 |
Why?
|
Hospitalization | 2 | 2024 | 10707 | 0.140 |
Why?
|
Time | 2 | 2023 | 545 | 0.140 |
Why?
|
Microbial Sensitivity Tests | 2 | 2021 | 1936 | 0.140 |
Why?
|
Neuroprotective Agents | 1 | 2023 | 956 | 0.140 |
Why?
|
Head and Neck Neoplasms | 1 | 2011 | 2894 | 0.140 |
Why?
|
Phylogeny | 2 | 2019 | 2809 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11733 | 0.140 |
Why?
|
Intensive Care Units | 4 | 2024 | 3744 | 0.140 |
Why?
|
Astrocytes | 1 | 2024 | 1341 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3634 | 0.130 |
Why?
|
Base Sequence | 3 | 2021 | 12404 | 0.130 |
Why?
|
Clindamycin | 1 | 2016 | 139 | 0.130 |
Why?
|
Demography | 1 | 2021 | 1641 | 0.130 |
Why?
|
Microglia | 1 | 2024 | 1358 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2018 | 20118 | 0.120 |
Why?
|
Virulence | 1 | 2019 | 1296 | 0.120 |
Why?
|
Oncogenes | 1 | 2021 | 1220 | 0.120 |
Why?
|
Anesthesia, General | 1 | 2002 | 1174 | 0.120 |
Why?
|
Anti-Bacterial Agents | 4 | 2020 | 7407 | 0.120 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2002 | 1490 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2023 | 1163 | 0.120 |
Why?
|
Streptococcal Infections | 1 | 2019 | 617 | 0.120 |
Why?
|
Halitosis | 1 | 2014 | 13 | 0.120 |
Why?
|
Sample Size | 1 | 2017 | 843 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1470 | 0.110 |
Why?
|
Clinical Coding | 1 | 2015 | 181 | 0.110 |
Why?
|
ROC Curve | 3 | 2024 | 3584 | 0.110 |
Why?
|
Workflow | 1 | 2018 | 850 | 0.110 |
Why?
|
Protein Array Analysis | 2 | 2006 | 399 | 0.110 |
Why?
|
Biofilms | 1 | 2018 | 625 | 0.110 |
Why?
|
Escherichia coli | 1 | 2006 | 4201 | 0.110 |
Why?
|
Quality Assurance, Health Care | 1 | 2023 | 2164 | 0.110 |
Why?
|
Oral Hygiene | 1 | 2014 | 132 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2015 | 15637 | 0.110 |
Why?
|
Drug Eruptions | 1 | 2016 | 335 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.110 |
Why?
|
Pseudomonas aeruginosa | 1 | 2020 | 1272 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15308 | 0.100 |
Why?
|
Therapeutics | 1 | 2013 | 113 | 0.100 |
Why?
|
Area Under Curve | 2 | 2014 | 1636 | 0.100 |
Why?
|
Bioengineering | 1 | 2012 | 99 | 0.090 |
Why?
|
Leukocytosis | 1 | 2012 | 251 | 0.090 |
Why?
|
Internet | 3 | 2015 | 3096 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2019 | 1160 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1893 | 0.090 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4612 | 0.090 |
Why?
|
Databases, Factual | 3 | 2017 | 7965 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1743 | 0.090 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 1448 | 0.090 |
Why?
|
Biotechnology | 1 | 2012 | 281 | 0.090 |
Why?
|
Odds Ratio | 1 | 2022 | 9652 | 0.090 |
Why?
|
Information Dissemination | 2 | 2015 | 1129 | 0.090 |
Why?
|
Brain Ischemia | 1 | 2023 | 3032 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 539 | 0.090 |
Why?
|
Critical Illness | 2 | 2013 | 2724 | 0.090 |
Why?
|
Information Storage and Retrieval | 2 | 2013 | 820 | 0.080 |
Why?
|
WT1 Proteins | 1 | 2010 | 184 | 0.080 |
Why?
|
Nephrons | 1 | 2010 | 168 | 0.080 |
Why?
|
Mouth Mucosa | 1 | 2011 | 432 | 0.080 |
Why?
|
Animals | 11 | 2024 | 168089 | 0.080 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2009 | 1053 | 0.080 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 465 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1506 | 0.080 |
Why?
|
Multigene Family | 1 | 2011 | 1075 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9417 | 0.070 |
Why?
|
DNA | 2 | 2013 | 7189 | 0.070 |
Why?
|
Forecasting | 2 | 2014 | 2928 | 0.070 |
Why?
|
United States | 4 | 2024 | 72341 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2017 | 12676 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 725 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2691 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1191 | 0.070 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2006 | 206 | 0.070 |
Why?
|
Mice | 7 | 2023 | 81330 | 0.070 |
Why?
|
Body Fluids | 1 | 2008 | 320 | 0.060 |
Why?
|
Systems Integration | 1 | 2008 | 428 | 0.060 |
Why?
|
Risk Factors | 3 | 2022 | 74241 | 0.060 |
Why?
|
Vocabulary, Controlled | 1 | 2006 | 167 | 0.060 |
Why?
|
Mutation | 3 | 2021 | 30004 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4921 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5321 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 416 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8457 | 0.060 |
Why?
|
Fluid Therapy | 1 | 2008 | 578 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13386 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3872 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 1348 | 0.060 |
Why?
|
Amplifiers, Electronic | 1 | 2004 | 16 | 0.060 |
Why?
|
Models, Molecular | 2 | 2019 | 5406 | 0.060 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2023 | 31 | 0.060 |
Why?
|
Automation | 1 | 2006 | 585 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2008 | 2263 | 0.060 |
Why?
|
Self-Help Devices | 1 | 2004 | 62 | 0.050 |
Why?
|
Signal Transduction | 4 | 2023 | 23419 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8606 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 502 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.050 |
Why?
|
Peptides | 2 | 2021 | 4353 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5301 | 0.050 |
Why?
|
Mass Spectrometry | 2 | 2007 | 2189 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9567 | 0.050 |
Why?
|
Azoles | 1 | 2021 | 22 | 0.050 |
Why?
|
Blood Proteins | 1 | 2007 | 1173 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 4243 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9721 | 0.050 |
Why?
|
Female | 10 | 2024 | 392552 | 0.050 |
Why?
|
Ceftazidime | 1 | 2020 | 57 | 0.050 |
Why?
|
Fetal Blood | 1 | 2007 | 1348 | 0.050 |
Why?
|
Aging | 1 | 2019 | 8702 | 0.040 |
Why?
|
Veterans Health | 1 | 2022 | 215 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7571 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2023 | 485 | 0.040 |
Why?
|
Fetus | 1 | 2007 | 1864 | 0.040 |
Why?
|
Tachycardia | 1 | 2002 | 599 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12101 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 3025 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 112 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3596 | 0.040 |
Why?
|
Parabens | 1 | 2019 | 114 | 0.040 |
Why?
|
Gene Expression | 2 | 2010 | 7571 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 273 | 0.040 |
Why?
|
Ergosterol | 1 | 2018 | 19 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 64681 | 0.040 |
Why?
|
Allosteric Regulation | 1 | 2019 | 424 | 0.040 |
Why?
|
Pregnancy | 3 | 2010 | 29893 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3517 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17598 | 0.030 |
Why?
|
Proteome | 1 | 2007 | 1856 | 0.030 |
Why?
|
Myelodysplastic Syndromes | 1 | 2007 | 1393 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2015 | 26200 | 0.030 |
Why?
|
Cohort Studies | 2 | 2024 | 41496 | 0.030 |
Why?
|
Biological Assay | 1 | 2019 | 623 | 0.030 |
Why?
|
Male | 8 | 2024 | 360703 | 0.030 |
Why?
|
Carbon | 1 | 2019 | 665 | 0.030 |
Why?
|
Equipment Design | 1 | 2004 | 3510 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1331 | 0.030 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2018 | 493 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 790 | 0.030 |
Why?
|
Models, Biological | 2 | 2014 | 9458 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 736 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2002 | 1780 | 0.030 |
Why?
|
Kidney | 1 | 2010 | 7033 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1540 | 0.030 |
Why?
|
Sulfur Compounds | 1 | 2014 | 32 | 0.030 |
Why?
|
Fungal Proteins | 1 | 2018 | 908 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2022 | 80675 | 0.030 |
Why?
|
Sulfides | 1 | 2014 | 168 | 0.030 |
Why?
|
Uric Acid | 1 | 2019 | 807 | 0.030 |
Why?
|
Dental Plaque | 1 | 2014 | 209 | 0.030 |
Why?
|
Volatile Organic Compounds | 1 | 2014 | 86 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 989 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2007 | 12747 | 0.030 |
Why?
|
Adult | 4 | 2024 | 221120 | 0.030 |
Why?
|
Italy | 1 | 2014 | 844 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2217 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 220858 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2020 | 1453 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3593 | 0.020 |
Why?
|
Dental Care | 1 | 2014 | 282 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 518 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3603 | 0.020 |
Why?
|
Genome, Human | 1 | 2022 | 4423 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 289 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4909 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3537 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14392 | 0.020 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2008 | 146 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1822 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1867 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2010 | 457 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 848 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2621 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14675 | 0.020 |
Why?
|
Research | 1 | 2015 | 1976 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6180 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2011 | 58952 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1900 | 0.020 |
Why?
|
Aged | 2 | 2024 | 169292 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 655 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5333 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1668 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9297 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2816 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24022 | 0.010 |
Why?
|
Pregnant Women | 1 | 2007 | 568 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2820 | 0.010 |
Why?
|
Leukemia | 1 | 2010 | 1518 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2010 | 2113 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12985 | 0.010 |
Why?
|
Lasers | 1 | 2005 | 952 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4567 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10553 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8642 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39957 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27094 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18384 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8531 | 0.010 |
Why?
|
Boston | 1 | 2008 | 9327 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13511 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6567 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17897 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9478 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18222 | 0.010 |
Why?
|
Child | 1 | 2014 | 80154 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 88300 | 0.000 |
Why?
|